Soaring Challenges in Antibody-Drug Conjugates: Navigating Target Selection and Managing Side Effects
Antibody-Drug Conjugates (ADCs) represent a dynamic and rapidly evolving frontier in targeted cancer therapy, combining the specificity of monoclonal antibodies ...
